Bluepharma, leader of the CInTech consortium, represented by António Lucas Nunes, General Manager of the Agenda and Director of Innovation at Bluepharma, presented the evolution of the project at the 2nd Annual Meeting of Mobilizing and Green Agendas for Business Innovation, within the scope of the Recovery and Resilience (PRR), which took place on March 12, 2024, at the Europarque in Santa Maria da Feira.
CInTech intends to promote the creation and training of the first Technological Hub entirely dedicated to complex injectable medicines in Portugal, in a global investment of 30 million euros corresponding to an incentive of around 21 million euros. The consortium also includes the University of Coimbra, the Iberian Institute of Nanotechnology, and three SMEs (Biotrend, JPM and Joinsteel).